Reagents For Molecular Diagnostic Test Systems

FDA classification

FDA Class 1 ·Reagents For Molecular Diagnostic Test Systems

Tomographic Imager Combining Emission Computed Tomography With Nuclear Magnetic Resonance

FDA classification

FDA Class 2 ·Tomographic Imager Combining Emission Computed Tomography With Nuclear Magnetic Resonance

Antigen, Cf, T. Cruzi

FDA classification

FDA Class 1 ·Antigen, Cf, T. Cruzi

Antigen, Inflammatory Response Marker, Sepsis

FDA classification

FDA Class 2 ·Antigen, Inflammatory Response Marker, Sepsis

Sealant, Pit And Fissure, And Conditioner

FDA classification

FDA Class 2 ·Sealant, Pit And Fissure, And Conditioner

Device To Detect And Measure Procalcitonin (Pct) In Human Clinical Specimens

FDA classification

FDA Class 2 ·Device To Detect And Measure Procalcitonin (Pct) In Human Clinical Specimens

Radioimmunoassay, Prolactin (Lactogen)

FDA classification

FDA Class 1 ·Radioimmunoassay, Prolactin (Lactogen)

Igm, Antigen, Antiserum, Control

FDA classification

FDA Class 2 ·Igm, Antigen, Antiserum, Control

Cabinet, Emission Computed Tomography System

FDA classification

FDA Class 2 ·Cabinet, Emission Computed Tomography System

Alzheimer’S Disease Pathology Assessment Test

FDA classification

FDA Class 2 ·Alzheimer’S Disease Pathology Assessment Test

Severe Combined Immunodeficiency Disorder (Scid) Newborn Screening Test System

FDA classification

FDA Class 2 ·Severe Combined Immunodeficiency Disorder (Scid) Newborn Screening Test System

Assay, Proliferation, In Vitro, T Lymphocyte

FDA classification

FDA Class 2 ·Assay, Proliferation, In Vitro, T Lymphocyte

Assay To Measure Pct To Aid In The Risk Assessment Of Critically Ill Patients On Their First Day Of Icu Admission

FDA classification

FDA Class 2 ·Assay To Measure Pct To Aid In The Risk Assessment Of Critically Ill Patients On Their First Day Of Icu Admission